8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof
    1.
    发明授权
    8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof 失效
    8-芳基-1,2,3,4-四氢异喹啉及其衍生物

    公开(公告)号:US4220778A

    公开(公告)日:1980-09-02

    申请号:US956467

    申请日:1978-10-30

    摘要: 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof having the formula ##STR1## and the non-toxic pharmacologically acceptable acid addition salts thereof; wherein R is hydrogen, benzyl, or an alkyl radical of 1 to 7 carbon atoms; R.sup.1 is hydrogen or an alkyl radical of 1 to 7 carbon atoms; R.sup.2 in each occurrence is hydrogen, an alkyl radical of 1 to 7 carbon atoms or alkoxy radical of 1 to 7 carbon atoms, alike or different; Ar is phenyl optionally substituted with one or more halogen, an alkyl radical of 1 to 7 carbon atoms, or alkoxy radical of 1 to 7 carbon atoms; and n is positive integer less than 4, are disclosed. These compounds are useful because of their anti-arrhythmic, antimicrobial and central nervous system activity.

    摘要翻译: 具有式“IMAGE”的8-芳基-1,2,3,4-四氢异喹啉及其衍生物及其无毒的药理学上可接受的酸加成盐; 其中R为氢,苄基或1至7个碳原子的烷基; R1是氢或1至7个碳原子的烷基; R 2在每次出现时是氢,1至7个碳原子的烷基或1至7个碳原子的烷氧基,相同或不同; Ar是任选被一个或多个卤素,1至7个碳原子的烷基或1至7个碳原子的烷氧基取代的苯基; 并且n是小于4的正整数。 这些化合物由于其抗心律不齐,抗微生物和中枢神经系统活性而有用。